"Anti-Obesity Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that increase energy expenditure and weight loss by neural and chemical regulation. Beta-adrenergic agents and serotoninergic drugs have been experimentally used in patients with non-insulin dependent diabetes mellitus (NIDDM) to treat obesity.
| Descriptor ID |
D019440
|
| MeSH Number(s) |
D27.505.954.427.140
|
| Concept/Terms |
Anti-Obesity Agents- Anti-Obesity Agents
- Agents, Anti-Obesity
- Anti Obesity Agents
- Anti-Obesity Drugs
- Anti Obesity Drugs
- Drugs, Anti-Obesity
- Antiobesity Drugs
- Drugs, Antiobesity
- Antiobesity Agents
- Agents, Antiobesity
Weight-Loss Agents- Weight-Loss Agents
- Agents, Weight-Loss
- Weight Loss Agents
- Weight-Loss Drugs
- Drugs, Weight-Loss
- Weight Loss Drugs
|
Below are MeSH descriptors whose meaning is more general than "Anti-Obesity Agents".
Below are MeSH descriptors whose meaning is more specific than "Anti-Obesity Agents".
This graph shows the total number of publications written about "Anti-Obesity Agents" by people in this website by year, and whether "Anti-Obesity Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 1 | 0 | 1 |
| 2009 | 0 | 1 | 1 |
| 2012 | 1 | 0 | 1 |
| 2017 | 11 | 5 | 16 |
| 2018 | 8 | 3 | 11 |
| 2019 | 2 | 3 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Anti-Obesity Agents" by people in Profiles.
-
Molecular exploration of combinational therapy of orlistat with metformin prevents the COVID-19 consequences in obese diabetic patients. Eur Rev Med Pharmacol Sci. 2021 Jan; 25(2):580-582.
-
Effects of Inulin Propionate Ester Incorporated into Palatable Food Products on Appetite and Resting Energy Expenditure: A Randomised Crossover Study. Nutrients. 2019 Apr 16; 11(4).
-
Quercetin and its derivative Q2 modulate chromatin dynamics in adipogenesis and Q2 prevents obesity and metabolic disorders in rats. J Nutr Biochem. 2019 07; 69:151-162.
-
Mendelian obesity, molecular pathways and pharmacological therapies: a review. Eur Rev Med Pharmacol Sci. 2019 Feb; 23(3):1357-1378.
-
Acclaimed anti-obesity drug fails to impress scouts for clinically important research. BMJ. 2019 01 30; 364:l464.
-
Management of Polypharmacy and Drug-Drug Interactions in HIV Patients: A 2-year Experience of a Multidisciplinary Outpatient Clinic AIDS Rev. 2019; 21(1):40-49.
-
Gender-related issues in the pharmacology of new anti-obesity drugs. Obes Rev. 2019 03; 20(3):375-384.
-
Metformin induces significant reduction of body weight, total cholesterol and LDL levels in the elderly - A meta-analysis. PLoS One. 2018; 13(11):e0207947.
-
Healthy Weight and Obesity Prevention: JACC Health Promotion Series. J Am Coll Cardiol. 2018 09 25; 72(13):1506-1531.
-
Semaglutide and GLP-1 analogues as weight-loss agents. Lancet. 2018 08 25; 392(10148):615-616.